Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Clinical trial finds PRAX-114 improves symptoms of perimenopausal depression

Aug. 17, 2021

JadiCell shows superior neurogenesis induction in model of viral-induced cognitive dysfunction

Aug. 12, 2021

Cali Biosciences initiates MERIT-1 study of long-acting ropivacaine for postoperative pain

Aug. 12, 2021

Anti-PRNP monoclonal antibody decreases tau pathology in mouse Alzheimer's disease model

Aug. 11, 2021

Mindset presents preclinical data for next-generation psychedelic drug families

Aug. 11, 2021

Stress hormones affect brain plasticity via distinct mechanisms

Aug. 10, 2021

SPNS2 inhibition may be useful in treating autoimmune disease

Aug. 10, 2021

Phase II MERIT study of AXS-05 achieves primary and key secondary endpoints

Aug. 10, 2021

Gruenenthal divulges glucocorticoid receptor modulators

Aug. 10, 2021

Signal peptide peptidase-like 2B has a pathogenic role in Alzheimer's disease

Aug. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...